Role of Chemopreventive Agents in Women at Increased Risk for Breast Cancer

March 18, 2019
Charles Shapiro, MD
Charles Shapiro, MD

Cancer Network spoke with Charles Shapiro, MD, about the USPSTF's stance on use of tamoxifen, raloxifene, and aromatase inhibitors to prevent breast cancer.

Cancer Network spoke with Charles Shapiro, MD, about the USPSTF's stance on use of tamoxifen, raloxifene, and aromatase inhibitors to prevent breast cancer.